Literature DB >> 10828845

Expression of vascular endothelial growth factor in response to high glucose in rat mesangial cells.

N H Kim1, H H Jung, D R Cha, D S Choi.   

Abstract

Diabetic nephropathy associated with hyperglycemia is characterized by glomerular hyperfiltration and endothelial dysfunction. Vascular endothelial growth factor (VEGF) is known to be primarily involved in neoangiogenesis and increased endothelial permeability. The purpose of this study was to investigate VEGF expression in response to high glucose in rat cultured mesangial cells and to identify its signal pathway via protein kinase C (PKC). Rat mesangial cells were cultured with different concentrations of glucose: normal (5 mM d-glucose), medium (15 mM d-glucose) and high (30 mm d-glucose). Calphostin-C as a PKC inhibitor and phorbol myristate acetate (PMA) as a PKC downregulator were instillated into culture media to evaluate the role of PKC in mediating the glucose-induced increase in VEGF expression. High glucose increased expression of VEGF at the mRNA and protein levels, identified by semi-quantitative RT-PCR and western blotting, within 3 h and in a time- and glucose concentration-dependent manner. Calphostin-C and PMA inhibited glucose-induced increases in VEGF expression at the mRNA and protein levels. In conclusion, high glucose can directly increase VEGF expression in rat mesangial cells via a PKC-dependent mechanism. These results suggest that VEGF could be a potential mediator of glomerular hyperfiltration and proteinuria in diabetic nephropathy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10828845     DOI: 10.1677/joe.0.1650617

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  16 in total

Review 1.  Glucose, VEGF-A, and diabetic complications.

Authors:  L E Benjamin
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

2.  Vasopressin regulates rat mesangial cell growth by inducing autocrine secretion of vascular endothelial growth factor.

Authors:  Atsuo Tahara; Junko Tsukada; Yuichi Tomura; Takeyuki Yatsu; Masayuki Shibasaki
Journal:  J Physiol Sci       Date:  2011-01-13       Impact factor: 2.781

3.  A biodegradable injectable implant sustains systemic and ocular delivery of an aldose reductase inhibitor and ameliorates biochemical changes in a galactose-fed rat model for diabetic complications.

Authors:  Jithan V Aukunuru; Gangadhar Sunkara; Surya P Ayalasomayajula; Jack DeRuiter; Randall C Clark; Uday B Kompella
Journal:  Pharm Res       Date:  2002-03       Impact factor: 4.200

Review 4.  Cellular mechanisms and treatment of diabetes vascular complications converge on reactive oxygen species.

Authors:  Catharine I Whiteside
Journal:  Curr Hypertens Rep       Date:  2005-04       Impact factor: 5.369

5.  Aldose reductase inhibitor ameliorates renal vascular endothelial growth factor expression in streptozotocin-induced diabetic rats.

Authors:  Joong Kyung Sung; Jang Hyun Koh; Mi Young Lee; Bo Hwan Kim; Soo Min Nam; Jae Hyun Kim; Jin Hee Yoo; So Hee Kim; Sun Won Hong; Eun Young Lee; Ran Choi; Choon Hee Chung
Journal:  Yonsei Med J       Date:  2010-05       Impact factor: 2.759

6.  Angiogenic microenvironment augments impaired endothelial responses under diabetic conditions.

Authors:  Abdul Q Sheikh; Courtney Kuesel; Toloo Taghian; Jennifer R Hurley; Wei Huang; Yigang Wang; Robert B Hinton; Daria A Narmoneva
Journal:  Am J Physiol Cell Physiol       Date:  2014-02-26       Impact factor: 4.249

7.  Glucose and TGFbeta2 modulate the viability of cultured human retinal pericytes and their VEGF release.

Authors:  Eileen K Vidro; Stephen Gee; Richard Unda; Jian-xing Ma; Andrew Tsin
Journal:  Curr Eye Res       Date:  2008-11       Impact factor: 2.424

8.  Resveratrol ameliorates high-glucose-induced hyperpermeability mediated by caveolae via VEGF/KDR pathway.

Authors:  Chong Tian; Rui Zhang; Xiaolei Ye; Changhui Zhang; Xin Jin; Yukio Yamori; Liping Hao; Xiufa Sun; Chenjiang Ying
Journal:  Genes Nutr       Date:  2012-09-16       Impact factor: 5.523

Review 9.  Association between neonatal hyperglycemia and retinopathy of prematurity: a meta-analysis.

Authors:  Chunyan Lei; Jianan Duan; Ge Ge; Meixia Zhang
Journal:  Eur J Pediatr       Date:  2021-06-11       Impact factor: 3.183

10.  Protein kinase C activation affects, via the mRNA-binding Hu-antigen R/ELAV protein, vascular endothelial growth factor expression in a pericytic/endothelial coculture model.

Authors:  M Amadio; C Osera; G Lupo; C Motta; F Drago; S Govoni; A Pascale
Journal:  Mol Vis       Date:  2012-08-01       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.